LGND 经营现金流历史(2016–2025)
LIGAND PHARMACEUTICALS INCORPORATED (LGND) 年度经营现金流历史(来自 SEC 财报)—— 每个财年经营活动产生的现金净额。
$49.4MFY2025 · FY2016 以来:$60.7M → $49.4M
| 财年 | 数值 | 同比 |
|---|---|---|
| FY2025 | $49.4M | -49.1% |
| FY2024 | $97.0M | +95.8% |
| FY2023 | $49.6M | -64.0% |
| FY2022 | $137.8M | +74.9% |
| FY2021 | $78.8M | +44.4% |
| FY2020 | $54.6M | +286.1% |
| FY2019 | -$29.3M | -115.1% |
| FY2018 | $194.1M | +119.1% |
| FY2017 | $88.6M | +45.8% |
| FY2016 | $60.7M | — |
数据来自 SEC XBRL 申报 · 仅供参考 · 非投资建议